Literature DB >> 23804643

Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH/gL/gO and gH/gL/UL128-131 in the virion envelope.

Momei Zhou1, Qin Yu, Anya Wechsler, Brent J Ryckman.   

Abstract

Herpesvirus glycoprotein complex gH/gL provides a core entry function through interactions with the fusion protein gB and can also influence tropism through receptor interactions. The Epstein-Barr virus gH/gL and gH/gL/gp42 serve both functions for entry into epithelial and B cells, respectively. Human cytomegalovirus (HCMV) gH/gL can be bound by the UL128-131 proteins or gO. The phenotypes of gO and UL128-131 mutants suggest that gO-gH/gL interactions are necessary for the core entry function on all cell types, whereas the binding of UL128-131 to gH/gL likely relates to a distinct receptor-binding function for entry into some specific cell types (e.g., epithelial) but not others (e.g., fibroblasts and neurons). There are at least eight isoforms of gO that differ by 10 to 30% of amino acids, and previous analysis of two HCMV strains suggested that some isoforms of gO function like chaperones, disassociating during assembly to leave unbound gH/gL in the virion envelope, while others remain bound to gH/gL. For the current report, we analyzed the gH/gL complexes present in the virion envelope of several HCMV strains, each of which encodes a distinct gO isoform. Results indicate that all strains of HCMV contain stable gH/gL/gO trimers and gH/gL/UL128-131 pentamers and little, if any, unbound gH/gL. TR, TB40/e, AD169, and PH virions contained vastly more gH/gL/gO than gH/gL/UL128-131, whereas Merlin virions contained mostly gH/gL/UL128-131, despite abundant unbound gO remaining in the infected cells. Suppression of UL128-131 expression during Merlin replication dramatically shifted the ratio toward gH/gL/gO. These data suggest that Merlin gO is less efficient than other gO isoforms at competing with UL128-131 for binding to gH/gL. Thus, gO diversity may influence the pathogenesis of HCMV through effects on the assembly of the core versus tropism gH/gL complexes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23804643      PMCID: PMC3754086          DOI: 10.1128/JVI.01167-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Distinct glycoprotein O complexes arise in a post-Golgi compartment of cytomegalovirus-infected cells.

Authors:  Regan N Theiler; Teresa Compton
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus.

Authors:  Corina M Borza; Lindsey M Hutt-Fletcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

3.  Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Towne long as BACs and site-directed mutagenesis using a PCR-based technique.

Authors:  Gabriele Hahn; Dietlind Rose; Markus Wagner; Sylvia Rhiel; Michael A McVoy
Journal:  Virology       Date:  2003-03-01       Impact factor: 3.616

4.  Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes.

Authors:  U Hobom; W Brune; M Messerle; G Hahn; U H Koszinowski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  In silico pattern-based analysis of the human cytomegalovirus genome.

Authors:  Isidore Rigoutsos; Jiri Novotny; Tien Huynh; Stephen T Chin-Bow; Laxmi Parida; Daniel Platt; David Coleman; Thomas Shenk
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates.

Authors:  Lucy Rasmussen; Aimee Geissler; Catherine Cowan; Amanda Chase; Mark Winters
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus.

Authors:  Lucy Rasmussen; Aimee Geissler; Mark Winters
Journal:  J Infect Dis       Date:  2003-02-24       Impact factor: 5.226

Review 8.  The human cytomegalovirus.

Authors:  Santo Landolfo; Marisa Gariglio; Giorgio Gribaudo; David Lembo
Journal:  Pharmacol Ther       Date:  2003-06       Impact factor: 12.310

9.  Two novel spliced genes in human cytomegalovirus.

Authors:  Parvis Akter; Charles Cunningham; Brian P McSharry; Aidan Dolan; Clare Addison; Derrick J Dargan; Aycan F Hassan-Walker; Vincent C Emery; Paul D Griffiths; Gavin W G Wilkinson; Andrew J Davison
Journal:  J Gen Virol       Date:  2003-05       Impact factor: 3.891

10.  UL74 of human cytomegalovirus contributes to virus release by promoting secondary envelopment of virions.

Authors:  Xiao Jing Jiang; Barbara Adler; Kerstin Laib Sampaio; Margarete Digel; Gerhard Jahn; Nicole Ettischer; York-Dieter Stierhof; Laura Scrivano; Ulrich Koszinowski; Michael Mach; Christian Sinzger
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

View more
  60 in total

1.  A trimeric capable gB CMV vaccine provides limited protection against a highly cell associated and epithelial tropic strain of cytomegalovirus in guinea pigs.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  J Gen Virol       Date:  2021-03-17       Impact factor: 3.891

2.  Specialization for Cell-Free or Cell-to-Cell Spread of BAC-Cloned Human Cytomegalovirus Strains Is Determined by Factors beyond the UL128-131 and RL13 Loci.

Authors:  Eric P Schultz; Jean-Marc Lanchy; Le Zhang Day; Qin Yu; Christopher Peterson; Jessica Preece; Brent J Ryckman
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  Influence of Human Cytomegalovirus Glycoprotein O Polymorphism on the Inhibitory Effect of Soluble Forms of Trimer- and Pentamer-Specific Entry Receptors.

Authors:  Nadja Brait; Tanja Stögerer; Julia Kalser; Barbara Adler; Ines Kunz; Max Benesch; Barbara Kropff; Michael Mach; Elisabeth Puchhammer-Stöckl; Irene Görzer
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

4.  A viral regulator of glycoprotein complexes contributes to human cytomegalovirus cell tropism.

Authors:  Gang Li; Christopher C Nguyen; Brent J Ryckman; William J Britt; Jeremy P Kamil
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

5.  Development of a Primary Human Cell Model for the Study of Human Cytomegalovirus Replication and Spread within Salivary Epithelium.

Authors:  Kristen M Morrison; Matthew J Beucler; Emily O Campbell; Margaret A White; Rachel E Boody; Keith C Wilson; William E Miller
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

6.  Limits and patterns of cytomegalovirus genomic diversity in humans.

Authors:  Nicholas Renzette; Cornelia Pokalyuk; Laura Gibson; Bornali Bhattacharjee; Mark R Schleiss; Klaus Hamprecht; Aparecida Y Yamamoto; Marisa M Mussi-Pinhata; William J Britt; Jeffrey D Jensen; Timothy F Kowalik
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

7.  The N Terminus of Human Cytomegalovirus Glycoprotein O Is Important for Binding to the Cellular Receptor PDGFRα.

Authors:  Cora Stegmann; Franziska Rothemund; Kerstin Laib Sampaio; Barbara Adler; Christian Sinzger
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

Review 8.  Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.

Authors:  Thomas J Gardner; Domenico Tortorella
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

9.  Restriction of Human Cytomegalovirus Infection by Galectin-9.

Authors:  Allison Abendroth; Brian P McSharry; Barry Slobedman; Emily A Machala; Selmir Avdic; Lauren Stern; Dirk M Zajonc; Chris A Benedict; Emily Blyth; David J Gottlieb
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

10.  Scanning Mutagenesis of Human Cytomegalovirus Glycoprotein gH/gL.

Authors:  Eric P Schultz; Jean-Marc Lanchy; Erin E Ellerbeck; Brent J Ryckman
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.